QR код

Lower Myeloperoxidase-ANCA Titres at Diagnosis Are Associated with End-Stage Kidney Disease Progression During Follow-Up in Rituximab-Treated Patients with Microscopic Polyangiitis

<i>Background and Objectives</i>: To investigate whether myeloperoxidase (MPO)-antineutrophil cytoplasmic antibody (ANCA) titres at diagnosis are associated with the risk of end-stage kidney disease (ESKD) progression in patients with microscopic polyangiitis (MPA) treated with rituximab. <i>Materia...

Повний опис

Збережено в:
Автори: Oh Chan Kwon, Jang Woo Ha, Yong-Beom Park, Sang-Won Lee
Формат: Artigo
Мова:Inglês
Опубліковано: MDPI AG 2025-10-01
Серія:Medicina
Предмети:
antineutrophil cytoplasmic antibody
microscopic polyangiitis
myeloperoxidase
end-stage kidney disease
rituximab
Онлайн доступ:https://www.mdpi.com/1648-9144/61/11/1892
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси